Vetoquinol Past Earnings Performance

Past criteria checks 5/6

Vetoquinol has been growing earnings at an average annual rate of 15.3%, while the Pharmaceuticals industry saw earnings declining at 0.9% annually. Revenues have been growing at an average rate of 8.8% per year. Vetoquinol's return on equity is 11%, and it has net margins of 10.5%.

Key information

15.3%

Earnings growth rate

16.2%

EPS growth rate

Pharmaceuticals Industry Growth	14.1%
Revenue growth rate	8.8%
Return on equity	11.0%
Net Margin	10.5%
Next Earnings Update	12 Sep 2024

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown

How Vetoquinol makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

BATS-CHIXE:VETOP Revenue, expenses and earnings (EUR Millions)
Date	Revenue	Earnings	G+A Expenses
31 Dec 23	529	56	0
30 Sep 23	527	57	90
30 Jun 23	525	59	181
31 Mar 23	533	53	179
31 Dec 22	540	48	178
30 Sep 22	538	48	180
30 Jun 22	537	48	182
31 Mar 22	529	55	179
31 Dec 21	521	63	176
30 Sep 21	504	52	165
30 Jun 21	487	40	154
31 Mar 21	457	30	151
31 Dec 20	427	19	147
30 Sep 20	418	25	145
30 Jun 20	408	31	143
31 Mar 20	402	30	141
31 Dec 19	396	29	139
30 Sep 19	385	31	139
30 Jun 19	374	33	139
31 Mar 19	371	35	137
31 Dec 18	368	36	135
30 Sep 18	360	36	133
30 Jun 18	352	36	131
31 Mar 18	352	36	130
31 Dec 17	352	35	130
30 Sep 17	354	32	129
30 Jun 17	356	29	127
31 Mar 17	353	28	126
31 Dec 16	350	28	124
30 Sep 16	349	27	124
30 Jun 16	348	25	124
31 Mar 16	345	25	123
31 Dec 15	343	24	122
30 Sep 15	338	26	120
30 Jun 15	333	28	118
31 Mar 15	324	27	115
31 Dec 14	315	26	113
30 Sep 14	309	25	110
30 Jun 14	304	24	108
31 Mar 14	302	24	107
31 Dec 13	300	24	105
30 Sep 13	298	22	104
30 Jun 13	297	21	103

Quality Earnings: VETOP has high quality earnings.

Growing Profit Margin: VETOP's current net profit margins (10.5%) are higher than last year (8.9%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: VETOP's earnings have grown by 15.3% per year over the past 5 years.

Accelerating Growth: VETOP's earnings growth over the past year (15.8%) exceeds its 5-year average (15.3% per year).

Earnings vs Industry: VETOP earnings growth over the past year (15.8%) exceeded the Pharmaceuticals industry 3%.

Return on Equity

High ROE: VETOP's Return on Equity (11%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/05/11 14:56
End of Day Share Price	2024/02/12 00:00
Earnings	2023/12/31
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Vetoquinol SA is covered by 12 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Carole Rozen	CA Cheuvreux
Arnaud Cadart	CIC Market Solutions (ESN)
Alexandre Letz	Gilbert Dupont